Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 3
2015 1
2016 1
2017 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
[Hypocomplementemic urticarial vasculitis syndrome].
Melboucy-Belkhir S, Glitho S, Caux F, Mekinian A, Fain O. Melboucy-Belkhir S, et al. Rev Prat. 2014 Jan;64(1):25. Rev Prat. 2014. PMID: 24649538 French. No abstract available.
Prolonged paradoxical response to anti-tuberculous treatment after infliximab.
Melboucy-Belkhir S, Flexor G, Stirnemann J, Morin AS, Boukari L, Polliand C, Cruaud P, Fain O. Melboucy-Belkhir S, et al. Int J Infect Dis. 2010 Sep;14 Suppl 3:e333-4. doi: 10.1016/j.ijid.2010.03.002. Epub 2010 Jun 25. Int J Infect Dis. 2010. PMID: 20579914 Free article. Review.
[Recurrent flush in a 70-year-old man].
Seneschal C, Garidi R, Coppin C, Khentache R, Belkhir F, Brihaye B, Melboucy-Belkhir S, Sené T. Seneschal C, et al. Among authors: melboucy belkhir s. Rev Med Interne. 2017 Jul;38(7):488-490. doi: 10.1016/j.revmed.2017.04.003. Epub 2017 May 3. Rev Med Interne. 2017. PMID: 28477949 French. No abstract available.
Recurrent acute pericarditis in Takayasu arteritis.
Melboucy-Belkhir S, Compain C, Sacré K, Bussone G, Chauveheid MP, Pasi N, Deschamps L, Mouthon L, Papo T. Melboucy-Belkhir S, et al. Int J Cardiol. 2013 Jun 5;166(1):263-5. doi: 10.1016/j.ijcard.2012.09.106. Epub 2012 Oct 2. Int J Cardiol. 2013. PMID: 23040996 No abstract available.
Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.
Larosa M, Le Guern V, Guettrot-Imbert G, Morel N, Abisror N, Morati-Hafsaoui C, Orquevaux P, Diot E, Doria A, Sarrot-Reynauld F, Limal N, Queyrel V, Souchaud-Debouverie O, Sailler L, Le Besnerais M, Goulenok T, Molto A, Pannier-Metzger E, Sentilhes L, Mouthon L, Lazaro E, Costedoat-Chalumeau N; GR2 Group. Larosa M, et al. Rheumatology (Oxford). 2022 Aug 30;61(9):3657-3666. doi: 10.1093/rheumatology/keab943. Rheumatology (Oxford). 2022. PMID: 35015828 Free PMC article.
[Herpes simplex encephalitis].
Morel P, Melboucy-Belkhir S, Mekinian A, Javaud N, Fain O. Morel P, et al. Among authors: melboucy belkhir s. Rev Prat. 2013 Nov;63(9):1196. Rev Prat. 2013. PMID: 24422283 French. No abstract available.
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study.
Murarasu A, Guettrot-Imbert G, Le Guern V, Yelnik C, Queyrel V, Schleinitz N, Ferreira-Maldent N, Diot E, Urbanski G, Pannier E, Lazaro E, Souchaud-Debouverie O, Orquevaux P, Belhomme N, Morel N, Chauvet E, Maurier F, Le Besnerais M, Abisror N, Goulenok T, Sarrot-Reynauld F, Deroux A, Pasquier E, de Moreuil C, Bezanahary H, Pérard L, Limal N, Langlois V, Calas A, Godeau B, Lavigne C, Hachulla E, Cohen F, Benhamou Y, Raffray L, de Menthon M, Tieulié N, Poindron V, Mouthon L, Larosa M, Eléfant E, Sentilhes L, Molto A, Deneux-Tharaux C, Costedoat-Chalumeau N; GR2 Study Group. Murarasu A, et al. Lancet Rheumatol. 2022 Dec;4(12):e842-e852. doi: 10.1016/S2665-9913(22)00308-3. Epub 2022 Nov 24. Lancet Rheumatol. 2022. PMID: 38261392
Rationale and efficacy of CD52 targeting in HTLV-1-associated myositis.
Cochereau D, Georgin-Lavialle S, Maisonobe T, Dubourg O, Melboucy-Belkhir S, Hermine O, Aouba A. Cochereau D, et al. Among authors: melboucy belkhir s. Joint Bone Spine. 2014 Jul;81(4):362-5. doi: 10.1016/j.jbspin.2014.01.019. Epub 2014 Apr 4. Joint Bone Spine. 2014. PMID: 24709000
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Groh M, Fenwarth L, Labro M, Boudry A, Fournier E, Wemeau M, Marceau-Renaut A, Daltro de Oliveira R, Abraham J, Barry M, Blanche P, Bodard Q, Braun T, Chebrek S, Decamp M, Durel CA, Forcade E, Gerfaud-Valentin M, Golfier C, Gourguechon C, Grardel N, Kosmider O, Martis N, Melboucy Belkhir S, Merabet F, Michon A, Moreau S, Morice C, Néel A, Nicolini FE, Pascal L, Pasquier F, Pieragostini A, Roche-Lestienne C, Rousselot P, Terriou L, Thiebaut-Bertrand A, Viallard JF, Preudhomme C, Kahn JE, Lefevre G, Duployez N; CEREO Collaborators. Groh M, et al. Among authors: melboucy belkhir s. Am J Hematol. 2024 Jun;99(6):1108-1118. doi: 10.1002/ajh.27306. Epub 2024 Apr 2. Am J Hematol. 2024. PMID: 38563187
13 results